Research
Metabolic adaptation
Metabolic dysfunction-associated steatotic liver disease (MASLD) is very common in individuals with type 2 diabetes.
Healthcare providers should be aware of the high prevalence of MASLD in their diabetic patients.
StrongSupportsmedium confidence
Metabolic dysfunction-associated steatotic liver disease (MASLD) is very common in type 2 diabetes individuals.
Why this rating
The claim is based on a review of existing literature.
Source
Treatment Modalities for Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Review Article
V. Damle et al. · Journal of Diabetology · 2026
DOI 10.4103/jod.jod_85_25
review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →